PNC Financial Services Group
UBIO

PNC Financial Services Group’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

PNC Financial Services Group’s Portfolio UBIO Stock Details UBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$44K – 4260
2018
Q3 		$44K Buy
+1,000
New +$40.4K ﹤0.01% 3078

Other funds holding UBIO

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

PNC Financial Services Group's UBIO Position: Q4 2018 in Review

PNC Financial Services Group sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q4 2018, closing a stake of 1,000 shares — an estimated $44K sold.

PNC Financial Services Group first reported a position in UBIO in Q3 2018 and held it in 1 quarter. The position peaked at $44K in Q3 2018. 7 funds tracked by Wall St. Rank hold UBIO as of Q4 2018.

  • PNC Financial Services Group reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q4 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 1,000 Proshares UltraPro NASDAQ Biotechnology shares in Q4 2018, an estimated $44K.
  • PNC Financial Services Group first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q3 2018 and held it in 1 quarter.
  • PNC Financial Services Group's Proshares UltraPro NASDAQ Biotechnology position peaked at $44K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q4 2018.

Based on PNC Financial Services Group's 13F filing for Q4 2018, filed 8 Feb 2019.